What's the FDA's Current Thinking on the Regulatory Oversight of Molecular Diagnostic Tests?

06/26/08

Alberto Guitierrez, PhD,
Deputy Director of New Product Evaluation, FDA's Office of In Vitro Diagnostic Device Evaluation and Saftey